Several reported studies suggests that ROCK2 may serve as a therapeutic target for treating neurodegenerative disorders such as Huntington’s disease (HD), Parkinson’s disease (PD), and Alzheimer’s disease [9–13]. This evidence concerns the gene ROCK2 and Parkinson disease.